X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cc-122 (3) 3
cancer (2) 2
lymphomas (2) 2
oncology (2) 2
abt-199 (1) 1
alpha production (1) 1
animals (1) 1
anti-inflammatory agents - chemistry (1) 1
antineoplastic agents - chemistry (1) 1
biological sciences (1) 1
brief report (1) 1
cardiovascular assessment (1) 1
cc-122 treatment (1) 1
cell line, tumor (1) 1
cell survival (1) 1
chiral inversion (1) 1
chronic lymphocytic leukemia (1) 1
clinical medicine (1) 1
clinical trials (1) 1
cll (1) 1
consortia (1) 1
deuterium (1) 1
dlbcl patients (1) 1
drug dosages (1) 1
duvelisib (1) 1
electrocardiography (1) 1
enantiomer (1) 1
exposure response analysis (1) 1
female (1) 1
humans (1) 1
ibrutinib (1) 1
idelalisib (1) 1
immune escape (1) 1
immune response (1) 1
immunology (1) 1
immunomodulatory drugs imids (1) 1
in-vitro (1) 1
index medicus (1) 1
inflammation - drug therapy (1) 1
international conferences (1) 1
lenalidomide (1) 1
leukocytes, mononuclear - cytology (1) 1
maintenance (1) 1
mechanism (1) 1
medical colleges (1) 1
medicine & public health (1) 1
medicine/public health, general (1) 1
metabolism (1) 1
metabolites (1) 1
mice (1) 1
mice, scid (1) 1
models, chemical (1) 1
molecules (1) 1
multidisciplinary sciences (1) 1
multiple myeloma (1) 1
multiple-myeloma (1) 1
neoplasm transplantation (1) 1
neoplasms - drug therapy (1) 1
neoplasms - immunology (1) 1
ofatumumab (1) 1
original research (1) 1
pathway (1) 1
pharmaceuticals (1) 1
pharmacokinetics (1) 1
pharmacology (1) 1
piperidones - chemistry (1) 1
pnas plus (1) 1
prescription drugs (1) 1
qt prolongation effect (1) 1
qt/qtcf (1) 1
quinazolinones - chemistry (1) 1
racemization (1) 1
rituximab (1) 1
stereoisomerism (1) 1
studies (1) 1
suppressor-cells (1) 1
t-cells (1) 1
thalidomide (1) 1
thalidomide - analogs & derivatives (1) 1
thalidomide - chemistry (1) 1
tumor necrosis factor-alpha - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


OncoImmunology, ISSN 2162-4011, 12/2016, Volume 5, Issue 12, pp. e1231290 - e1231290
In the three patients included in a phase I clinical trial (NCT01421524), we report the immunomodulatory effects and efficacy of CC-122, a novel pleiotropic... 
DLBCL patients | immune response | CC-122 treatment | ONCOLOGY | PATHWAY | IMMUNE ESCAPE | SUPPRESSOR-CELLS | IMMUNOLOGY | T-CELLS
Journal Article
Journal Article
Clinical Pharmacology: Advances and Applications, ISSN 1179-1438, 09/2016, Volume 8, pp. 117 - 125
CC-122 hydrochloride is a novel pleiotropic pathway modifier compound that binds cereblon, a substrate receptor of the Cullin 4 RING E3 ubiquitin ligase... 
Cardiovascular assessment | QT prolongation effect | Consortia | Studies | Electrocardiography | International conferences | Lymphomas | Clinical medicine | Drug dosages | Cancer | Pharmaceuticals | cardiovascular assessment | exposure response analysis | CC-122 | QT/QTcF
Journal Article
memo - Magazine of European Medical Oncology, ISSN 1865-5041, 9/2015, Volume 8, Issue 3, pp. 159 - 161
At the annual meeting of the American Society of Hematology 2014 in San Francisco, a variety of important clinical trials covering topics like first-line... 
CLL | Rituximab | Oncology | Ofatumumab | Maintenance | Medicine/Public Health, general | Ibrutinib | Chronic lymphocytic leukemia | Medicine & Public Health | Duvelisib | Idelalisib | ABT-199 | CC-122 | Medical colleges | Lymphomas
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.